Plain-English translation of NCT07402018 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study follows patients with severe heart failure who are receiving a mechanical device called an intra-aortic balloon counterpulsation (IABC) device to help their heart pump better. Researchers will measure how flexible your blood vessels are and how well your heart responds to the device over time. The goal is to understand which patients benefit most from this treatment.
When the heart is severely weakened, doctors need better tools to predict which treatments will help each patient recover. This study aims to discover whether a patient's blood vessel flexibility can help doctors decide if this heart support device is the right choice, and to design better studies for the future.
You likely qualify if…
You likely don't qualify if…
You will have heart function measurements taken before the device is inserted, then again at 30 minutes, 3–6 hours, and 24 hours after the procedure — these are routine measurements your doctors would normally do anyway. After that, you'll continue regular follow-up care as your doctors monitor your recovery, whether that leads to improvement, device exchange, transplant, a permanent heart pump, or other outcomes. The study continues until your device support is no longer needed.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States